[1] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[2] |
SU Xin, FAN Wenyi, XU Xinye, XU Xuedong.
Analysis of risk factors and attributable disease burden of four major chronic diseases including cancer in the Chinese population
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 442-447.
|
[3] |
LI Shuimei, XU Sujuan, YIN Hai, ZHONG Yanmei, LIU Yingying, LIANG Jingyan.
Machine learning-based analysis of risk factors for postoperative facial paralysis in patients with parotid tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 481-486.
|
[4] |
LI Wei, LIU Ligang, YANG Junquan, LIU Chun, ZHANG Zhixue, GAO Fuchun, ZHANG Caixia, LIU Shuhong, LI Xinyu.
Analysis of the risk factors of anastomotic leakage after total laparoscopic transrectal specimen extraction surgery (NOSES Ⅳ) for colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 564-569.
|
[5] |
JIANG Zhou, HUANG Haixin, CHEN Dagui, YANG Hui, WU Sibei, XU Zhuohua, LU Ying.
Risk factors of vertebral artery stenosis after intensity-modulated radiation therapy for nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(3): 347-351.
|
[6] |
LIU Jinlu, QIN Xingan, LI Changhua, LUO Yihuan, CHEN Junqiang.
Risk factors and prognostic analysis of lymph node metastasis in No.14v group in gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 69-74.
|
[7] |
WU Yuanyuan, WANG Jun, MAO Aihong, FAN Xiangda, ZHANG Jianwei, DUAN Ying.
Establishment and verification of a scoring system for predicting central lymph node metastasis in papillary thyroid carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 498-502.
|
[8] |
Qin Yijia,Huang Bing,Lao Qifang,Zhang Lizhen.
Effect of different ventilation modes on the expression of S100A8 protein in patients undergoing pulmonary lobectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 465-468.
|
[9] |
Liu Lingfeng,Geng Yichao,OuYang Weiwei,Ma Zhu,Li Qingsong,Li Mei, Wang Yu,Luo Daxian,Yang Wengang,Su Shengfa,He Zhixu,Lu bing.
Comparison of clinical efficacy of cisplatin combined with pemetrexed or docetaxel in stage Ⅳ lung adenocarcinoma based on propensity score matching
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 290-294.
|
[10] |
Hu Hongbo,Lei Hao,Mo Qiyan,Li Ling,Qu Song,Liang Xia,Zhu Xiaodong,Zhao Wei.
Clinical characteriestics of second primary tumors in patients with nasopharyngeal carci-noma after intensity-modulated radiotherapy:series of 527 cases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 305-309.
|
[11] |
Yu Xueting,Yang Bo,Wei Zheng,Huang Gaoming.
Factors influencing image T residue at the end of intensity-modulated radiotherapy for nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 221-225.
|
[12] |
Xu Yi,Tang Shicong, Zhou xin,Xu Xiang,Huang Yaoyuan, Wang Shoufeng,Pan Hong.
Relationship between clinicopathological features of primary human non-small cell lung cancer and their tumorigenicity in nude mice
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 128-132.
|
[13] |
Liang Liudan,Li Yani,Song Xiangqun,Zhou Shaozhang.
Role of the mTOR signaling pathway in the ability of 17-DMAG to overcome acquired resistance to alectinib in the H3122 lung cancer cell line positive for the EML4-ALK fusion gene
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 111-118.
|
[14] |
Zhao Yifan,Xiao Chunyang,Xian Lei.
Expression and clinical significance of angiopoietin-1 mRNA in lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 139-142.
|
[15] |
Chen Qun,Shi Qin,Xie Qiang.
Preliminary study of recombinant human endostatin (Endostar) combined with concurrent intensity-modulated radiation therapy for inoperable local advanced non-small cell lung cancer in elderly patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 142-145.
|